Mortality Prognostic Model for Peripheral Arterial Disease

Slides:



Advertisements
Similar presentations
© 2010, American Heart Association. All rights reserved. A Validated Risk Score for In-hospital Mortality in Patients with Heart Failure from the American.
Advertisements

Frans H. Rutten, Nicolaas P. A. Zuithoff, EelkoHak, Diederick E. Grobbee, Arno W. Hoes Arch Intern Med. 2010;170(10): Beta-blockers may reduce.
Development and Testing of a Risk Assessment Model for Venous Thrombosis in Medical Inpatients: The Medical Inpatients and Thrombosis (MITH) Study Score.
Inappropriate clopidogrel adherence explains stent related adverse outcomes Leonardo Tamariz, MD, MPH University of Miami.
Is low-dose Aspirin use associated with a reduced risk of colorectal cancer ? a QResearch primary care database analysis Prof Richard Logan, Dr Yana Vinogradova,
NCHS Data – Strengths and Weaknesses from the NHLBI Perspective Paul Sorlie, Ph.D. Chief, Epidemiology Branch National Heart, Lung, and Blood Institute.
Safety and effectiveness of bivalirudin in routine care of patients undergoing percutaneous coronary intervention JA Rassen, MA Mittleman, RJ Glynn, A.
Prognostic Implications of Left Ventricular Mass and Geometry Following Myocardial Infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) Echocardiographic.
Validation of Mayo Clinic Risk Adjustment Model for In-Hospital Mortality following Percutaneous Coronary Interventions using the National Cardiovascular.
The effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries Dr. Christian Finley MD MPH FRCSC McMaster University.
Complete Recovery of Renal Function After Acute Kidney Injury is Associated with Long-Term All-Cause Mortality In a Large Managed Care Organization Jennifer.
Cognitive Impairment: An Independent Predictor of Excess Mortality SACHS, CARTER, HOLTZ, ET AL. ANN INTERN MED, SEP, 2011;155: ZACHARY LAPAQUETTE.
Multiple risk factors raise ischaemic stroke risk comparable to AF in the elderly: A large Chinese insurance analysis from 425,600 Chinese individuals.
Outcomes surveillance using routinely collected health data Paul Aylin Professor of Epidemiology and Public Health Dr Foster Unit at Imperial College London.
Long-Term Prognostic Value for Patients with Chronic Heart Failure of Estimated Glomerular Filtration Rate Calculated with the New CKD-EPI Equations Containing.
Long Term Clinical Outcomes Following Drug-Eluting and Bare Metal Stenting in Massachusetts Laura Mauri, MD, MSc; Treacy Silverstein, B.Sc.; Ann Lovett,
©2015 MFMER | The Effect of Disclosing Genomic Risk of Coronary Heart Disease on LDL Cholesterol Levels: The Myocardial Infarction Genes (MI-GENES)
Raghavan Murugan, MD, MS, FRCP Associate Professor of Critical Care Medicine, and Clinical & Translational Science Core Faculty, Center for Critical Care.
A Claims Database Approach to Evaluating Cardiovascular Safety of ADHD Medications A. J. Allen, M.D., Ph.D. Child Psychiatrist, Pharmacologist Global Medical.
Phenotype generation from EMR by tensor factorization SEDI Durham Cohort James Lu M.D. Ph.D. Department of Electrical and Computer Engineering Department.
CoRPS Center of Research on Psychology in Somatic diseases Brief Depression Screening with the PHQ-2 Predicts Poor Prognosis following PCI with Drug-Eluting.
Date of download: 7/5/2016 Copyright © 2016 American Medical Association. All rights reserved. From: A Prognostic Risk Index for Long-term Mortality in.
F. 정 회 훈 Am J Gastroenterol 2012;107:46-52 Risk of Hepatocellular Carcinoma in Diabetic Patients and Risk Reduction Associated With Anti-Diabetic Therapy:
Bootstrap and Model Validation
- Higher SBP visit-to-visit variability (SBV) has been associated
a cautionary note from SPRINT
CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation 
a cautionary note from SPRINT
The Importance of Adequately Powered Studies
Anastasiia Raievska (Veramed)
Suicide Mortality Following VA Irregular Discharges:
Health and Human Services National Heart, Lung, and Blood Institute
Mayo Clinic College of Medicine
Survival Analysis: From Square One to Square Two Yin Bun Cheung, Ph.D. Paul Yip, Ph.D. Readings.
Clinical need for determination of vulnerable plaques
Alina M. Allen MD, Patrick S. Kamath MD, Joseph J. Larson,
Table 1 Characteristics of study population, by pneumococcal vaccination status. From: Prior Pneumococcal Vaccination Is Associated with Reduced Death,
Evaluating Policies in Cardiovascular Medicine
Development and Validation of HealthImpactTM: An Incident Diabetes Prediction Model Based on Administrative Data Rozalina G. McCoy, M.D.1, Vijay S. Nori,
Menachem M Meller,MD, PhD
Ageing with ideal cardiovascular risk factors
Bleeding and cancer risk in patients with vascular disease COMPASS Steering Committee and Investigators.
More Than Survival: Futility
Adjusted mortality risk
Comparison between Kaplan-Meier survival estimates of Bristol aortic valve surgery patients and the Monte Carlo-based generated Kaplan-Meier curve using.
Innovative Informatics Approaches for Peripheral Artery Disease: Current State and Provider Survey of Strategies for Improving Guideline-Based Care  Alisha.
Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL.
Prevalence of statin and beta-blocker use by clinical presentation
Chronic kidney disease and cause-specific hospitalisation: a matched cohort study using primary and secondary care patient data by Masao Iwagami, Ben Caplin,
Proportion of Sudden Unexpected Death in North Carolina (SUDDEN) men and women with coronary artery disease (CAD) aged 56–64 years by source of medical.
Insights from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
A: Kaplan-Meier estimate of time to first LLA
Diabetes Journal Club March 17, 2011
Heart failure.
Mining peripheral arterial disease cases from narrative clinical notes using natural language processing  Naveed Afzal, PhD, Sunghwan Sohn, PhD, Sara.
IP029. Incorporating Patient and Anatomic Factors in Predicting Operative Mortality of Abdominal Aortic Aneurysm Repair: A Robust Risk Score Calculator 
Significance of Periprocedural Myocardial Infarctions in Percutaneous Coronary Interventions A New Look at an Old Topic Abhiram Prasad, MD, FRCP, FESC,
Impact of Hepatitis C, HIV, or Both on Survival in Veterans in Care Before and After the Introduction of HAART (1996) SL Fultz, MD, MPH CH Chang, PhD AA.
No Financial Disclosure or Conflict of Interest
M Javanbakht, S Guerry, LV Smith, P Kerndt
Characteristics of 21,484 Patients With MI Who Survived for >30 Days After Discharge, by Calendar Year - Part I Soko Setoguchi, et al. J Am Coll Cardiol.
Identifying Low-Risk Patients with Pulmonary Embolism Suitable For Outpatient Treatment A VERITY Registry Pilot Study N Scriven, T Farren, S Bacon, T.
Baseline Clinical Characteristics of All Patients and Patients Grouped by Statin Therapy - Part I H. Fukuta et al. Circulation 2005;112:
Kaplan-Meier estimation of diabetes-related survival curves in patients grouped according to increased 24-h proteinuria (A), the presence of preexisting.
Low/moderate intensity statins High intensity statins
Figure 2. Associations of comorbidities with PD in elderly participants in the multivariate regression analysis. The multivariate Cox proportional-hazards.
Prognostic value of ankle-brachial index and dobutamine stress echocardiography for cardiovascular morbidity and all-cause mortality in patients with.
Low/moderate intensity statins High intensity statins
Figure Prevalence of coronary artery disease by year or
Identification of thresholds for significant renal recovery in relation to patient and renal survival. Identification of thresholds for significant renal.
Presentation transcript:

Mortality Prognostic Model for Peripheral Arterial Disease Adelaide M. Arruda-Olson MD, PhD, Naveed Afzal PhD, Homam Moussa Pacha MBBS, Ahmad Said MD, Bradley Lewis MS, Christopher Scott MS, Kent Bailey PhD, Hongfang Liu PhD, Iftikhar J. Kullo MD

Background Peripheral artery disease is common High morbidity and mortality Management is often suboptimal Prognostic models for PAD not available Gerhard-Herman et al, Circ 2016; Kullo & Rooke, NEJM, 2016 Feringa et al, Arch Int Med 2007; Goldstein, JAMIA 2017

Objectives Extract risk factors from the integrated health information system of Rochester Epidemiology Project Create a mortality prognostic model for PAD patients, which can be deployed at the point of care

Rochester Epidemiology Project Unique identification numbers to each person Matches medical records of participating institutions to specific individuals Geographically defined population of Olmsted County Olmsted County, Minnesota

Participating Institutions - REP

Billing Code Algorithms PAD Integer score for each code (ICD-9 or procedural codes) Score ≥ 8 = PAD cases Fan J, Arruda-Olson AM, et al. JAMIA , 2013 Comorbidities 12 comorbidities ICD-9 billing codes Deyo et al. J Clin Epidemiol ,1992

Diagnostic Criteria for PAD ABI ≤ 0.90 rest or post-exercise ≥20% decrease ABI after exercise ABI >1.40 = poorly compressible arteries Results - vascular laboratory dataset Gerhard-Herman, Circulation 2016 Kullo & Rooke, NEJM, 2016

Outcome: All-Cause Mortality Sources for death information Electronic Minnesota state death certificates National death index Sauver JL et al. Int J Epidemiol 2012;41(6):1614-24

Cox Proportional Hazards Regression Age, sex, prior revascularization, ABI Forced into models Age2 Non-linear association of age with mortality risk Comorbidities Chosen based on number of times present in 10-fold cross validation of stepwise selection

Statistical Analysis Survival c-statistics Summarize predictive ability of models Based on cross-validation Calibration Defined risk groups in each derivation set Applied to cross-validation sets. Survival and hazard ratios estimated for each risk group

Olmsted residents with PAD n = 1676 72±13 yrs, 45% women PAD by ABI 5-year follow-up or Died n = 1565 593 deaths

Prognostic Model “A” for 5-Year Mortality Parameter Beta estimate HR 95% CI p value Age2 0.081 1.08 1.04 1.13 <0.0001 Female sex -0.221 0.80 0.68 0.95 0.01 Cross Validation C-Statistic 0.70 95% CI: 0.68 - 0.73 Prior Revascularization 0.492 1.64 1.28 2.08 <0.0001 PCA 0.852 2.34 1.88 2.92 ABI Value (continuous) per 0.1 -0.089 0.92 0.88 0.95 Unknown ABI value 0.383 1.45 1.07 2.01 0.02

Prognostic Model “B” for 5-Year Mortality Parameter Beta estimate HR 95% CI p value Age2 0.076 1.08 1.04 1.12 0.0002 Female sex -0.165 0.85 0.72 1.00 0.06 Prior Revascularization 0.461 1.59 1.24 2.02 0.0002 PCA 0.566 1.76 1.40 2.22 <0.0001 ABI Value (continuous) per 0.1 -0.074 0.93 0.89 0.97 0.0007 Cross Validation C-Statistic 0.75 95% CI 0.73, 0.77 Diabetes 0.321 1.38 1.16 1.64 0.0003 Lung disease 0.332 1.39 1.18 1.65 0.0001 Renal disease 0.414 1.51 1.27 1.80 <0.0001 History of heart failure 0.634 1.89 1.58 2.24 Dementia 0.562 1.76 1.43 2.16 Statin -0.383 0.68 0.57 0.81

Risk Groups – Model “B” Risk Groups N deaths (N ) HR 95% CI p value Low risk (score ≤ -0.17) 18 (268) 0.35 0.21 0.58 <0.0001 Low-intermediate (-0.17 ≤ score < 0.70) 104 (570) reference Intermediate-high (0.70 ≤ score <1.85) 257 2.98 2.37 3.74 High (score ≥ 1.85) 214 8.44 6.66 10.70

Kaplan-Meier curves by risk subgroups Model A Model B Cumulative survival Years Years Low risk derivation Intermediate low risk derivation Intermediate high risk derivation High risk derivation Low risk validation Intermediate low risk validation Intermediate high risk validation High risk validation

Strengths and Limitations Applied electronic phenotyping algorithms to integrated health information system of the REP and to vascular laboratory dataset Community PAD patients, inpatient or outpatient Robust internal validation Future studies needed for external validation

Conclusions Automated data mining of an integrated health information system generates prognostic models for death in PAD patients 2 models Model A c-statistic = 0.70 (0.68 - 0.73) Model B c-statistic = 0.75 (0.73 - 0.77) Patients in the highest risk group had HR 8.44 (6.66 - 10.70) compared to reference group

Clinical Implications These models have potential for translation to patient care and could be used for automated risk calculators to be deployed at the point of care

Acknowledgements Grants NHLBI - K01HL124045 NHGRI - HG04599 and HG006379 NIA - R01AG034676 NIGMS - R01GM102283A1

ArrudaOlson.Adelaide@mayo.edu